OvaScience Welcomes John Sexton, President of New York University, To Board Of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScience? (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today the appointment of John E. Sexton, Ph.D., President of New York University (NYU), to the OvaScience Board of Directors.

Help employers find you! Check out all the jobs and post your resume.

Back to news